Recall D-0447-2026

US Class II Ongoing · initiated 2026-03-24

Recalling firm

GE Healthcare Ireland Limited

Product

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

Reason for recall

Presence of particulate matter

← All recalls